Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)

Market Cap	2.75B -17.2%
Revenue (ttm)	1.72B -18.2%
Net Income	-349.70M
EPS	-0.45
Shares Out	784.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,269,163
Open	3.590
Previous Close	3.610
Day's Range	3.500 - 3.680
52-Week Range	2.850 - 5.270
Beta	0.20
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHA:600594

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells novel pharmaceutical products in China. The company offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, dripping pills, and oral solutions in the areas of tumor system, cerebrovascular and cardiovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, gynecological, tonic, oncology, orthopedics, gastroenterolog...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 4,832
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600594

Financial Performance

In 2025, SHA:600594's revenue was 1.86 billion, a decrease of -14.31% compared to the previous year's 2.17 billion. Losses were -329.56 million, 3.89% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 30, 2026

Data Sources Report a data error